Report Details

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti Obesity Drugs Anti obesity Medication Market Size Comparison by Region (M USD)
Table 5.Global Anti Obesity Drugs Anti obesity Medication Sales (K MT) by Manufacturers (2018-2023)
Table 6.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Manufacturers (2018-2023)
Table 7.Global Anti Obesity Drugs Anti obesity Medication Revenue (M USD) by Manufacturers (2018-2023)
Table 8.Global Anti Obesity Drugs Anti obesity Medication Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Obesity Drugs Anti obesity Medication as of 2022)
Table 10.Global Market Anti Obesity Drugs Anti obesity Medication Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Anti Obesity Drugs Anti obesity Medication Sales Sites and Area Served
Table 12. Manufacturers Anti Obesity Drugs Anti obesity Medication Product Type
Table 13.Global Anti Obesity Drugs Anti obesity Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti Obesity Drugs Anti obesity Medication
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti Obesity Drugs Anti obesity Medication Market Challenges
Table 22. Market Restraints
Table 23.Global Anti Obesity Drugs Anti obesity Medication Sales by Type (K MT)
Table 24.Global Anti Obesity Drugs Anti obesity Medication Market Size by Type (M USD)
Table 25.Global Anti Obesity Drugs Anti obesity Medication Sales (K MT) by Type (2018-2023)
Table 26.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Type (2018-2023)
Table 27.Global Anti Obesity Drugs Anti obesity Medication Market Size (M USD) by Type (2018-2023)
Table 28.Global Anti Obesity Drugs Anti obesity Medication Market Size Share by Type (2018-2023)
Table 29.Global Anti Obesity Drugs Anti obesity Medication Price (USD/MT) by Type (2018-2023)
Table 30.Global Anti Obesity Drugs Anti obesity Medication Sales (K MT) by Application
Table 31.Global Anti Obesity Drugs Anti obesity Medication Market Size by Application
Table 32.Global Anti Obesity Drugs Anti obesity Medication Sales by Application (2018-2023) & (K MT)
Table 33.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Application (2018-2023)
Table 34.Global Anti Obesity Drugs Anti obesity Medication Sales by Application (2018-2023) & (M USD)
Table 35.Global Anti Obesity Drugs Anti obesity Medication Market Share by Application (2018-2023)
Table 36.Global Anti Obesity Drugs Anti obesity Medication Sales Growth Rate by Application (2018-2023)
Table 37.Global Anti Obesity Drugs Anti obesity Medication Sales by Region (2018-2023) & (K MT)
Table 38.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Region (2018-2023)
Table 39. North America Anti Obesity Drugs Anti obesity Medication Sales by Country (2018-2023) & (K MT)
Table 40. Europe Anti Obesity Drugs Anti obesity Medication Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Anti Obesity Drugs Anti obesity Medication Sales by Region (2018-2023) & (K MT)
Table 42. South America Anti Obesity Drugs Anti obesity Medication Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Anti Obesity Drugs Anti obesity Medication Sales by Region (2018-2023) & (K MT)
Table 44. Zafgan Anti Obesity Drugs Anti obesity Medication Basic Information
Table 45. Zafgan Anti Obesity Drugs Anti obesity Medication Product Overview
Table 46. Zafgan Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Zafgan Business Overview
Table 48. Zafgan Anti Obesity Drugs Anti obesity Medication SWOT Analysis
Table 49. Zafgan Recent Developments
Table 50. Vivus Anti Obesity Drugs Anti obesity Medication Basic Information
Table 51. Vivus Anti Obesity Drugs Anti obesity Medication Product Overview
Table 52. Vivus Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Vivus Business Overview
Table 54. Vivus Anti Obesity Drugs Anti obesity Medication SWOT Analysis
Table 55. Vivus Recent Developments
Table 56. Shionogi Anti Obesity Drugs Anti obesity Medication Basic Information
Table 57. Shionogi Anti Obesity Drugs Anti obesity Medication Product Overview
Table 58. Shionogi Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Shionogi Business Overview
Table 60. Shionogi Anti Obesity Drugs Anti obesity Medication SWOT Analysis
Table 61. Shionogi Recent Developments
Table 62. Sanofi Anti Obesity Drugs Anti obesity Medication Basic Information
Table 63. Sanofi Anti Obesity Drugs Anti obesity Medication Product Overview
Table 64. Sanofi Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Sanofi Business Overview
Table 66. Sanofi Anti Obesity Drugs Anti obesity Medication SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Rhythm Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Basic Information
Table 69. Rhythm Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Product Overview
Table 70. Rhythm Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Rhythm Pharmaceuticals Business Overview
Table 72. Rhythm Pharmaceuticals Anti Obesity Drugs Anti obesity Medication SWOT Analysis
Table 73. Rhythm Pharmaceuticals Recent Developments
Table 74. Pfizer Anti Obesity Drugs Anti obesity Medication Basic Information
Table 75. Pfizer Anti Obesity Drugs Anti obesity Medication Product Overview
Table 76. Pfizer Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Pfizer Business Overview
Table 78. Pfizer Recent Developments
Table 79. Orexigen Therapeutics Anti Obesity Drugs Anti obesity Medication Basic Information
Table 80. Orexigen Therapeutics Anti Obesity Drugs Anti obesity Medication Product Overview
Table 81. Orexigen Therapeutics Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Orexigen Therapeutics Business Overview
Table 83. Orexigen Therapeutics Recent Developments
Table 84. Novo Nordisk Anti Obesity Drugs Anti obesity Medication Basic Information
Table 85. Novo Nordisk Anti Obesity Drugs Anti obesity Medication Product Overview
Table 86. Novo Nordisk Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Novo Nordisk Business Overview
Table 88. Novo Nordisk Recent Developments
Table 89. Norgine Anti Obesity Drugs Anti obesity Medication Basic Information
Table 90. Norgine Anti Obesity Drugs Anti obesity Medication Product Overview
Table 91. Norgine Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Norgine Business Overview
Table 93. Norgine Recent Developments
Table 94. Nalpropion Pharmaceuticals Inc. Anti Obesity Drugs Anti obesity Medication Basic Information
Table 95. Nalpropion Pharmaceuticals Inc. Anti Obesity Drugs Anti obesity Medication Product Overview
Table 96. Nalpropion Pharmaceuticals Inc. Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Nalpropion Pharmaceuticals Inc. Business Overview
Table 98. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 99. Merck Anti Obesity Drugs Anti obesity Medication Basic Information
Table 100. Merck Anti Obesity Drugs Anti obesity Medication Product Overview
Table 101. Merck Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Merck Business Overview
Table 103. Merck Recent Developments
Table 104. GlaxoSmithKline Anti Obesity Drugs Anti obesity Medication Basic Information
Table 105. GlaxoSmithKline Anti Obesity Drugs Anti obesity Medication Product Overview
Table 106. GlaxoSmithKline Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. F.Hoffmann-La Roche Anti Obesity Drugs Anti obesity Medication Basic Information
Table 110. F.Hoffmann-La Roche Anti Obesity Drugs Anti obesity Medication Product Overview
Table 111. F.Hoffmann-La Roche Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. F.Hoffmann-La Roche Business Overview
Table 113. F.Hoffmann-La Roche Recent Developments
Table 114. Eisai Anti Obesity Drugs Anti obesity Medication Basic Information
Table 115. Eisai Anti Obesity Drugs Anti obesity Medication Product Overview
Table 116. Eisai Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Eisai Business Overview
Table 118. Eisai Recent Developments
Table 119. Boehringer Ingelheim Anti Obesity Drugs Anti obesity Medication Basic Information
Table 120. Boehringer Ingelheim Anti Obesity Drugs Anti obesity Medication Product Overview
Table 121. Boehringer Ingelheim Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Boehringer Ingelheim Business Overview
Table 123. Boehringer Ingelheim Recent Developments
Table 124. Bayer AG Anti Obesity Drugs Anti obesity Medication Basic Information
Table 125. Bayer AG Anti Obesity Drugs Anti obesity Medication Product Overview
Table 126. Bayer AG Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Bayer AG Business Overview
Table 128. Bayer AG Recent Developments
Table 129. AstraZeneca Anti Obesity Drugs Anti obesity Medication Basic Information
Table 130. AstraZeneca Anti Obesity Drugs Anti obesity Medication Product Overview
Table 131. AstraZeneca Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Recent Developments
Table 134. Arena Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Basic Information
Table 135. Arena Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Product Overview
Table 136. Arena Pharmaceuticals Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Arena Pharmaceuticals Business Overview
Table 138. Arena Pharmaceuticals Recent Developments
Table 139. Amylin Anti Obesity Drugs Anti obesity Medication Basic Information
Table 140. Amylin Anti Obesity Drugs Anti obesity Medication Product Overview
Table 141. Amylin Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. Amylin Business Overview
Table 143. Amylin Recent Developments
Table 144. Alizyme Anti Obesity Drugs Anti obesity Medication Basic Information
Table 145. Alizyme Anti Obesity Drugs Anti obesity Medication Product Overview
Table 146. Alizyme Anti Obesity Drugs Anti obesity Medication Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Alizyme Business Overview
Table 148. Alizyme Recent Developments
Table 149.Global Anti Obesity Drugs Anti obesity Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 150.Global Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Region (2024-2029) & (M USD)
Table 151. North America Anti Obesity Drugs Anti obesity Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 152. North America Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Country (2024-2029) & (M USD)
Table 153. Europe Anti Obesity Drugs Anti obesity Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 154. Europe Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Country (2024-2029) & (M USD)
Table 155. Asia Pacific Anti Obesity Drugs Anti obesity Medication Sales Forecast by Region (2024-2029) & (K MT)
Table 156. Asia Pacific Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Region (2024-2029) & (M USD)
Table 157. South America Anti Obesity Drugs Anti obesity Medication Sales Forecast by Country (2024-2029) & (K MT)
Table 158. South America Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Country (2024-2029) & (M USD)
Table 159. Middle East and Africa Anti Obesity Drugs Anti obesity Medication Consumption Forecast by Country (2024-2029) & (Units)
Table 160. Middle East and Africa Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Country (2024-2029) & (M USD)
Table 161.Global Anti Obesity Drugs Anti obesity Medication Sales Forecast by Type (2024-2029) & (K MT)
Table 162.Global Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Type (2024-2029) & (M USD)
Table 163.Global Anti Obesity Drugs Anti obesity Medication Price Forecast by Type (2024-2029) & (USD/MT)
Table 164.Global Anti Obesity Drugs Anti obesity Medication Sales (K MT) Forecast by Application (2024-2029)
Table 165.Global Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Application (2024-2029) & (M USD)
List of Figures
Figure 1. Product Picture of Anti Obesity Drugs Anti obesity Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4.Global Anti Obesity Drugs Anti obesity Medication Market Size (M USD), 2018-2029
Figure 5.Global Anti Obesity Drugs Anti obesity Medication Market Size (M USD) (2018-2029)
Figure 6.Global Anti Obesity Drugs Anti obesity Medication Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti Obesity Drugs Anti obesity Medication Market Size by Country (M USD)
Figure 11. Anti Obesity Drugs Anti obesity Medication Sales Share by Manufacturers in 2022
Figure 12.Global Anti Obesity Drugs Anti obesity Medication Revenue Share by Manufacturers in 2022
Figure 13. Anti Obesity Drugs Anti obesity Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14.Global Market Anti Obesity Drugs Anti obesity Medication Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. TheGlobal 5 and 10 Largest Players: Market Share by Anti Obesity Drugs Anti obesity Medication Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17.Global Anti Obesity Drugs Anti obesity Medication Market Share by Type
Figure 18. Sales Market Share of Anti Obesity Drugs Anti obesity Medication by Type (2018-2023)
Figure 19. Sales Market Share of Anti Obesity Drugs Anti obesity Medication by Type in 2022
Figure 20. Market Size Share of Anti Obesity Drugs Anti obesity Medication by Type (2018-2023)
Figure 21. Market Size Market Share of Anti Obesity Drugs Anti obesity Medication by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23.Global Anti Obesity Drugs Anti obesity Medication Market Share by Application
Figure 24.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Application (2018-2023)
Figure 25.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Application in 2022
Figure 26.Global Anti Obesity Drugs Anti obesity Medication Market Share by Application (2018-2023)
Figure 27.Global Anti Obesity Drugs Anti obesity Medication Market Share by Application in 2022
Figure 28.Global Anti Obesity Drugs Anti obesity Medication Sales Growth Rate by Application (2018-2023)
Figure 29.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share by Region (2018-2023)
Figure 30. North America Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Anti Obesity Drugs Anti obesity Medication Sales Market Share by Country in 2022
Figure 32. U.S. Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Anti Obesity Drugs Anti obesity Medication Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Anti Obesity Drugs Anti obesity Medication Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Anti Obesity Drugs Anti obesity Medication Sales Market Share by Country in 2022
Figure 37. Germany Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti Obesity Drugs Anti obesity Medication Sales Market Share by Region in 2022
Figure 44. China Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (K MT)
Figure 50. South America Anti Obesity Drugs Anti obesity Medication Sales Market Share by Country in 2022
Figure 51. Brazil Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti Obesity Drugs Anti obesity Medication Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Anti Obesity Drugs Anti obesity Medication Sales and Growth Rate (2018-2023) & (K MT)
Figure 61.Global Anti Obesity Drugs Anti obesity Medication Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62.Global Anti Obesity Drugs Anti obesity Medication Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63.Global Anti Obesity Drugs Anti obesity Medication Sales Market Share Forecast by Type (2024-2029)
Figure 64.Global Anti Obesity Drugs Anti obesity Medication Market Share Forecast by Type (2024-2029)
Figure 65.Global Anti Obesity Drugs Anti obesity Medication Sales Forecast by Application (2024-2029)
Figure 66.Global Anti Obesity Drugs Anti obesity Medication Market Share Forecast by Application (2024-2029)